CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has been selected as one of MIT Technology Review’s 2010 TR50 in its first annual list of the 50 most innovative companies in the world. This list spans many industries, including energy, computing, the Web, biomedicine, and materials. Each company on the list was evaluated based on its business model, strategies for deploying and scaling up its technologies, and the likelihood of success.
